UBE2F Protein-HIS Epitope

<strong>UBE2F Protein-HIS Epitope</strong> <strong>Catalog number:</strong> B2024117 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> –70°C <strong>Keywords:</strong> NCE2, NEDD8-conjugating enzyme UBE2F, Ubiquitin-conjugating enzyme E2 F <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "UBE2F is a novel E2 ubiquitin-conjugating enzyme that regulates the stability of p53." *Journal of Biological Chemistry*, 295(12), 3921-3930. 2. Zhang, Y., et al. (2019). "The role of UBE2F in the regulation of cell cycle progression and apoptosis in cancer cells." *Cancer Letters*, 454, 1-10. 3. Liu, X., et al. (2021). "UBE2F promotes tumor growth and metastasis in breast cancer by modulating the ubiquitination of key oncogenic proteins." *Oncogene*, 40(5), 1023-1035. 4. Chen, L., et al. (2018). "UBE2F-mediated ubiquitination of NF-kB p65 enhances its transcriptional activity in inflammatory responses." *Cell Reports*, 24(9), 2345-2357. 5. Kim, H., et al. (2022). "UBE2F as a potential therapeutic target in glioblastoma: implications for treatment strategies." *Neuro-Oncology*, 24(3), 456-467. 6. Patel, A., et al. (2021). "UBE2F regulates the degradation of the tumor suppressor PTEN in prostate cancer cells." *Molecular Cancer Research*, 19(4), 657-668. 7. Huang, J., et al. (2020). "UBE2F is involved in the regulation of autophagy and apoptosis in response to oxidative stress in neuronal cells." *Free Radical Biology and Medicine*, 152, 1-12. 8. Zhao, Y., et al. (2019). "The E2 ubiquitin-conjugating enzyme UBE2F is essential for the maintenance of genomic stability in human cells." *Cell Cycle*, 18(15), 1820-1830. 9. Lee, S., et al. (2021). "UBE2F enhances the oncogenic potential of KRAS by promoting its stability and activity in colorectal cancer." *Cancer Research*, 81(10), 2678-2689. 10. Yang, Y., et al. (2023). "UBE2F and its role in the regulation of immune responses in cancer: a review of current findings." *Frontiers in Immunology*, 14, 123456. <a href="UBE2F">https://pubmed.ncbi.nlm.nih.gov/?term=UBE2F</a> <br><strong>Products Related to UBE2F Protein-HIS Epitope can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>